![Joseph Walewicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Walewicz
Director/Board Member at
NEUPATH HEALTH INC.
Net worth: 565 553 $ as of 30/06/2026
Profile
Joseph Walewicz is currently Director at NeuPath Health, Inc. since 2026.
Former positions include Independent Director at Warnex, Inc. from 2011 to 2014; Executive Director of Equity Research at CIBC World Markets, Inc. from 2005 to 2008; Director at Klinik Health Ventures Corp.; Equity Research Associate of Biotechnology at Lehman Brothers, Inc.; Vice President at Paladin Labs, Inc. from 2009 to 2011; Vice President of Equity Research at BMO Nesbitt Burns, Inc. (US); Vice President & Senior Health Care Analyst at Orion Securities, Inc. from 2004 to 2005; Vice President-Business & Corporate Development at Mirati Therapeutics, Inc. from 2011 to 2013; Healthcare Analyst at Laurentian Bank Securities, Inc. from 2014 to 2017; Member at Licensing Executives Society USA & Canada, Inc.; Executive VP-Business & Corporate Development at Clementia Pharmaceuticals, Inc. from 2017 to 2019; and Chief Financial Officer at Fibrocor Therapeutics, Inc. from 2021 to 2022.
Education includes an MBA from McGill University and an undergraduate degree from Queen's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEUPATH HEALTH INC. 2.24% | 11/06/2026 | 12,34,832 ( 2.24% ) | 565 553 $ | 30/06/2026 |
Joseph Walewicz active positions
| Companies | Position | Start |
|---|---|---|
| NEUPATH HEALTH INC. | Director/Board Member | 25/06/2020 |
Former positions of Joseph Walewicz
| Companies | Position | End |
|---|---|---|
Fibrocor Therapeutics LP
 Fibrocor Therapeutics LP BiotechnologyHealth Technology Develops tissue-specific therapeutics for fibrotic diseases | Director of Finance/CFO | 01/03/2022 |
| CLEMENTIA PHARMACEUTICALS INC | Investor Relations Contact | 01/01/2019 |
Laurentian Bank Securities, Inc.
 Laurentian Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/04/2017 |
| WARNEX INC. | Director/Board Member | 01/01/2014 |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 01/01/2013 |
Training of Joseph Walewicz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Warnex, Inc.
 Warnex, Inc. Medical SpecialtiesHealth Technology Provides laboratory services to the pharmaceutical and healthcare sectors | Health Technology |
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
BMO Nesbitt Burns, Inc. (US) | Finance |
Orion Securities, Inc.
 Orion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
CIBC World Markets, Inc.
 CIBC World Markets, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laurentian Bank Securities, Inc.
Laurentian Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Licensing Executives Society USA & Canada, Inc.
 Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Commercial Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
Fibrocor Therapeutics LP
Fibrocor Therapeutics LP BiotechnologyHealth Technology Develops tissue-specific therapeutics for fibrotic diseases | Health Technology |
Klinik Health Ventures Corp.
 Klinik Health Ventures Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
NeuPath Health, Inc.
 NeuPath Health, Inc. Financial ConglomeratesFinance Provides chronic pain management services | Finance |
- Stock Market
- Insiders
- Joseph Walewicz
